Trevena, Inc. (TRVN) Social Stream
Trevena Inc (TRVN) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering TRVN.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
TRVN's average price target has moved down $0.25 over the prior 42 weeks.
TRVN reports an average of 303.87% for its upside potential over the past 33 weeks.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
TRVN Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
TRVN's average broker recommendation rating improved by 0.58 over the prior 31 days.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- To contextualize these metrics, consider that out of all US stocks, Trevena Inc's variance in analysts' estimates is lower than almost 100% of them.
- TRVN has a greater upside potential (average analyst target price relative to current price) than 96.58% of stocks in the small market cap category.
- In the context of Pharmaceutical Products stocks, Trevena Inc's average analyst price target is higher than 5.44% of them.
- TRVN has a greater number of analysts covering the stock than 12.55% of Healthcare stocks.
Is TRVN a Buy, Hold or Sell? See the POWR Ratings now!